Nevro Announces FDA Approval of its 10 kHz High Frequency Spinal Cord Stimulation Therapy for Treatment of Chronic Pain Associated with Painful Diabetic Neuropathy (PDN)
HFX for PDN Now the Only Spinal Cord Stimulation System Approved by FDA to Treat PDN¹
Company Will Immediately Initiate Commercial Launch Activities in the U.S.
Company Announces Preliminary, Unaudited Second Quarter 2021 Revenue of Approximate... Devices, Neurology, FDA, Product Launch Nevro Corp, Senza , diabetic neuropathy, spinal cord stimulation
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Back Pain | Brain | Chronic Pain | Diabetes | Endocrinology | Neurology | Pain | Pharmaceuticals